These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17548393)

  • 1. Novice drivers with attention-deficit hyperactivity disorder.
    Jerome L
    CMAJ; 2007 Jun; 176(12):1735. PubMed ID: 17548393
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Hergüner S; Tanidir C
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate and the cytochrome P450 system.
    Baird R
    Can J Psychiatry; 2003 Jul; 48(6):425-6; author reply 426. PubMed ID: 12894619
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 6. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC; Cox DJ
    J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate (Ritalin) use and abuse.
    Crutchley A; Temlett JA
    S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.
    Cox DJ; Merkel RL; Kovatchev B; Seward R
    J Nerv Ment Dis; 2000 Apr; 188(4):230-4. PubMed ID: 10790000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
    Verster JC; Roth T
    J Clin Psychopharmacol; 2014 Oct; 34(5):633-6. PubMed ID: 24978156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does methylphenidate influence cognitive performance?
    Solanto MV
    J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1323-5. PubMed ID: 9334541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 14. Question 3. Should stimulants be administered to manage difficulties with attention, hyperactivity and impulsivity following paediatric acquired brain injury?
    Harvey DW; Morrall M; Neilly E; Murdoch-Eaton D
    Arch Dis Child; 2012 Aug; 97(8):755-8. PubMed ID: 22859431
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Long-acting stimulants for novice drivers with ADHD.
    Jerome L
    Can J Psychiatry; 2007 Sep; 52(9):614. PubMed ID: 17953166
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of long-term stimulants on driving in adults with ADHD.
    Jerome L; Segal A
    J Nerv Ment Dis; 2001 Jan; 189(1):63-4. PubMed ID: 11206669
    [No Abstract]   [Full Text] [Related]  

  • 18. The possible effect of methylphenidate on secondary encopresis in children with attention-deficit/hyperactivity disorder.
    Bilgiç A
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):647. PubMed ID: 21130131
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
    Tomás Vila M; Aleu Pérez-Gramunt M; Beseler Soto B; Benac Prefasi M; Pantoja Martínez J; Pitarch Castellano I
    An Pediatr (Barc); 2010 Aug; 73(2):78-83. PubMed ID: 20605120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
    Cox DJ; Merkel RL; Penberthy JK; Kovatchev B; Hankin CS
    J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):269-75. PubMed ID: 15076259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.